Skip to main content
Find a DoctorGet Care Now
Skip to main content
Search icon magnifying glass

Contrast

Contact

Share

Donate

MyChart

Help

Free skin cancer screenings offered at Smilow Cancer Hospital in Waterford

Friday, April 27, 2018

NEW LONDON, CT – April 27, 2018 – Free skin cancer screenings will be available at the Smilow Cancer Hospital Care Center in Waterford on Monday, May 7, from 5 to 7:30 pm. The care center is located at 230 Waterford Parkway South.

The screenings will be conducted by Yale Medicine Dermatology and dermatologists on the Lawrence + Memorial Hospital medical staff.

Screenings are by appointment only. To reserve an appointment, please call 860-271-4617.

The five-year survival rate for melanoma when detected and treated in its early stage is 98%. Nearly 9,500 people in the United States are diagnosed with skin cancer every day. An estimated one in five Americans will develop skin cancer in their lifetime.

Funding for these screenings are provided by the annual Jackson King Memorial Golf Tournament.

Similar Articles

1/8/2026

Lawrence + Memorial Hospital NICU recognized with Beacon Award for Excellence

New London, CT (Jan. 6, 2025) – The American Association of Critical-Care Nurses (AACN) has recognized the Neonatal Intensive Care Unit (NICU) at Lawrence + Memorial Hospital with a silver-level Beacon Award for Excellence – the first NICU in the state to earn this recognition.

12/9/2025

Lawrence + Memorial Hospital recognized as 2026 High Performing hospital for Maternity Care by U.S. News & World Report

New London, CT (Dec. 9, 2025) – Lawrence + Memorial Hospital (L+M) has been named a 2026 High Performing hospital for Maternity Care by U.S. News & World Report.

12/2/2025

Lawrence + Memorial Hospital offers new procedure for atrial fibrillation

New London, CT (Dec. 1, 2025) – Cardiac electrophysiologists at Lawrence + Memorial (L+M) Hospital recently performed a new procedure to treat atrial fibrillation (AFib) – the most common abnormal heart rhythm (cardiac arrhythmia) and the second most common cardiac condition in the United States, affecting more than eight million people.